Let’s start a petition to have MDMA and psilocybin and other psychedelics to be approved through the TDA for trials and to use to treat PTSD, anxiety and depression etc

How does MDMA assist with psychotherapy?
MDMA might be able to assist psychotherapy because it decreases defensiveness and anxiety, increases relaxation, and improves mood.5 It may also improve the bond between the therapist and the patient.5

What this means in practice is that a person may be more able to revisit the traumatic memories and work through the emotions attached to them without being re-traumatised or finding the associated anxiety or fear too overwhelming to continue the session.5

Because MDMA appears to reduce anxiety associated with recalling traumatic experiences, it can enable increased insight and memory.5

Negative memories may be perceived as less confronting, allowing the therapist and the patient to engage in productive therapeutic sessions, without the patient becoming hyper-aroused due to stress.

In combination with psychotherapy, the use of MDMA provides the capacity “to hold the traumatised patient in a state of emotional security, providing a state of empathic self-reflection in which, for the first time in their lives, they can be with their traumatic memories without being overwhelmed by the powerful negative affect that usually accompanies recall of their most frightening thoughts”.

Combining the psychedelic drug psilocybin with supportive psychotherapy results in substantial rapid and enduring antidepressant effects among patients with major depressive disorder, according to a new randomized clinical trial overseas. New study provides more evidence that psilocybin, a compound found in so-called magic mushrooms, can be a helpful tool in the treatment of psychiatric conditions.